XML 60 R32.htm IDEA: XBRL DOCUMENT v3.25.0.1
Insider Trading Arrangements
 3 Months Ended 12 Months Ended
Dec. 31, 2024
shares
Dec. 31, 2024
shares
Trading Arrangements, by Individual    
Non-Rule 10b5-1 Arrangement Adopted false  
Rule 10b5-1 Arrangement Terminated false  
Non-Rule 10b5-1 Arrangement Terminated false  
Christopher Jewell [Member]    
Trading Arrangements, by Individual    
Material Terms of Trading Arrangement   On December 23, 2024, Christopher Jewell, our Chief Scientific Officer, adopted a trading plan intended to satisfy the conditions under Rule 10b5-1(c) of the Exchange Act. Dr. Jewell’s plan provides for the exercise of vested stock options and the potential associated sale of up to 15,000 shares of our common stock until and including December 31, 2025. The foregoing exercises or sales, if any, will be made in accordance with the prices and formulas set forth in the plan and such plan terminates on the earlier of the date all the shares under the plan are sold and December 31, 2025.
Name Christopher Jewell  
Title Chief Scientific Officer  
Rule 10b5-1 Arrangement Adopted true  
Adoption Date December 23, 2024  
Expiration Date December 31, 2025  
Arrangement Duration 373 days  
Aggregate Available 15,000 15,000